These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26304544)

  • 1. Cooperation meets competition in microRNA-mediated DMPK transcript regulation.
    Koscianska E; Witkos TM; Kozlowska E; Wojciechowska M; Krzyzosiak WJ
    Nucleic Acids Res; 2015 Oct; 43(19):9500-18. PubMed ID: 26304544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development.
    Michel L; Huguet-Lachon A; Gourdon G
    PLoS One; 2015; 10(9):e0137620. PubMed ID: 26339785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanded CUG repeats in
    van Cruchten RTP; Wieringa B; Wansink DG
    RNA; 2019 Apr; 25(4):481-495. PubMed ID: 30700578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A low absolute number of expanded transcripts is involved in myotonic dystrophy type 1 manifestation in muscle.
    Gudde AE; González-Barriga A; van den Broek WJ; Wieringa B; Wansink DG
    Hum Mol Genet; 2016 Apr; 25(8):1648-62. PubMed ID: 26908607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental insights into the pathology of and therapeutic strategies for DM1: Back to the basics.
    Chau A; Kalsotra A
    Dev Dyn; 2015 Mar; 244(3):377-90. PubMed ID: 25504326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structural basis of myotonic dystrophy from the crystal structure of CUG repeats.
    Mooers BH; Logue JS; Berglund JA
    Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16626-31. PubMed ID: 16269545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ hybridization analysis of Dmpk mRNA in adult mouse tissues.
    Sarkar PS; Han J; Reddy S
    Neuromuscul Disord; 2004 Sep; 14(8-9):497-506. PubMed ID: 15336691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of modified antisense oligonucleotides targeting DMPK in mice and nonhuman primates for the treatment of myotonic dystrophy type 1.
    Pandey SK; Wheeler TM; Justice SL; Kim A; Younis HS; Gattis D; Jauvin D; Puymirat J; Swayze EE; Freier SM; Bennett CF; Thornton CA; MacLeod AR
    J Pharmacol Exp Ther; 2015 Nov; 355(2):329-40. PubMed ID: 26330536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of myogenesis in transgenic mice expressing the human DMPK 3'-UTR.
    Storbeck CJ; Drmanic S; Daniel K; Waring JD; Jirik FR; Parry DJ; Ahmed N; Sabourin LA; Ikeda JE; Korneluk RG
    Hum Mol Genet; 2004 Mar; 13(6):589-600. PubMed ID: 14734627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-183 potentially inhibits NF-κB1 expression by directly targeting its 3'-untranslated region.
    Sha F; Wu S; Zhang H; Guo X
    Acta Biochim Biophys Sin (Shanghai); 2014 Nov; 46(11):991-6. PubMed ID: 25274328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis.
    Wang DT; Ma ZL; Li YL; Wang YQ; Zhao BT; Wei JL; Qi X; Zhao XT; Jin YX
    Oncol Rep; 2013 Jul; 30(1):492-8. PubMed ID: 23670238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental identification of microRNA targets on the 3' untranslated region of human FMR1 gene.
    Yi YH; Sun XS; Qin JM; Zhao QH; Liao WP; Long YS
    J Neurosci Methods; 2010 Jun; 190(1):34-8. PubMed ID: 20435064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myotonic dystrophy associated expanded CUG repeat muscleblind positive ribonuclear foci are not toxic to Drosophila.
    Houseley JM; Wang Z; Brock GJ; Soloway J; Artero R; Perez-Alonso M; O'Dell KM; Monckton DG
    Hum Mol Genet; 2005 Mar; 14(6):873-83. PubMed ID: 15703191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput analysis of the RNA-induced silencing complex in myotonic dystrophy type 1 patients identifies the dysregulation of miR-29c and its target ASB2.
    Cappella M; Perfetti A; Cardinali B; Garcia-Manteiga JM; Carrara M; Provenzano C; Fuschi P; Cardani R; Renna LV; Meola G; Falcone G; Martelli F
    Cell Death Dis; 2018 Jun; 9(7):729. PubMed ID: 29955039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of binding site arrangement and combinatorial targeting in microRNA repression of gene expression.
    Hon LS; Zhang Z
    Genome Biol; 2007; 8(8):R166. PubMed ID: 17697356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myotonic dystrophy: candidate small molecule therapeutics.
    Konieczny P; Selma-Soriano E; Rapisarda AS; Fernandez-Costa JM; Perez-Alonso M; Artero R
    Drug Discov Today; 2017 Nov; 22(11):1740-1748. PubMed ID: 28780071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium Channel Inhibitors Reduce DMPK mRNA and Protein.
    Witherspoon L; O'Reilly S; Hadwen J; Tasnim N; MacKenzie A; Farooq F
    Clin Transl Sci; 2015 Aug; 8(4):298-304. PubMed ID: 26011798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
    de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
    Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells.
    Janaki Ramaiah M; Lavanya A; Honarpisheh M; Zarea M; Bhadra U; Bhadra MP
    Gene; 2014 Dec; 552(2):255-64. PubMed ID: 25261849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.